Decreased Effectiveness of a Novel Opioid Withdrawal Protocol Following the Emergence of Medetomidine as a Fentanyl Adulterant.

London, K., Durney, P., Warrick-Stone, T., Alexander, K., Kahoud, J. (2025). Decreased Effectiveness of a Novel Opioid Withdrawal Protocol Following the Emergence of Medetomidine as a Fentanyl Adulterant. BioMed, 5 (2), 13. https://doi.org/10.3390/biomed5020013